Publications

Export 24 results:
Auteur Title Type [ Année(Asc)]
Filtres: Auteur is Alzheimer's Disease Neuroimaging Initiative  [Enlever les filtres]
2021
Therriault J, Pascoal TA, Sefranek M, Mathotaarachchi S, Benedet AL, Chamoun M, Lussier FZ, Tissot C, Bellaver B, Lukasewicz PS et al..  2021.  Amyloid-dependent and amyloid-independent effects of Tau in individuals without dementia.. Ann Clin Transl Neurol. 8(10):2083-2092.
Picard C, Nilsson N, Labonte A, Auld D, Rosa-Neto P, Ashton NJ, Zetterberg H, Blennow K, Breitner JCS, Villeneuve S et al..  2021.  Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease.. Alzheimers Dement.
Bussy A, Plitman E, Patel R, Tullo S, Salaciak A, Bedford SA, Farzin S, Béland M-L, Valiquette V, Kazazian C et al..  2021.  Hippocampal subfield volumes across the healthy lifespan and the effects of MR sequence on estimates.. Neuroimage. 233:117931.
Chan NK, Gerretsen P, Chakravarty MM, Blumberger DM, Caravaggio F, Brown E, Graff-Guerrero A.  2021.  Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy.. Am J Geriatr Psychiatry. 29(4):319-332.
2019
Tam A, Dansereau C, Iturria-Medina Y, Urchs S, Orban P, Sharmarke H, Breitner JCS, Bellec P.  2019.  A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia.. Gigascience. 8(5)
Meyer P-F, Savard M, Poirier J, Morgan D, Breitner JCS.  2019.  Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology.. Alzheimers Dement. 15(9):1160-1171.
2018
Therriault J, Ng KPin, Pascoal TA, Mathotaarachchi S, Kang MSu, Struyfs H, Shin M, Benedet AL, Walpola IC, Nair V et al..  2018.  Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.. Neurology. 90(11):e932-e939.
Miron J, Picard C, Nilsson N, Frappier J, Dea D, Théroux L, Poirier J.  2018.  CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.. Alzheimers Dement.
Benedet AL, Yu L, Labbe A, Mathotaarachchi S, Pascoal TA, Shin M, Kang M-S, Gauthier S, Rouleau GA, Poirier J et al..  2018.   variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.. Neurol Genet. 4(1):e216.
2017
Zandifar A, Fonov V, Coupé P, Pruessner J, D Collins L.  2017.  A comparison of accurate automatic hippocampal segmentation methods.. Neuroimage. 155:383-393.
Mathotaarachchi S, Pascoal TA, Shin M, Benedet AL, Kang MSu, Beaudry T, Fonov VS, Gauthier S, Rosa-Neto P.  2017.  Identifying incipient dementia individuals using machine learning and amyloid imaging.. Neurobiol Aging. 59:80-90.
Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M.  2017.  Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.. Neurology. 88(6):569-576.
Ng KPin, Pascoal TA, Mathotaarachchi S, Chung C-O, Benedet AL, Shin M, Kang MSu, Li X, Ba M, Kandiah N et al..  2017.  Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.. Neurology. 88(19):1814-1821.
Ba M, Li X, Ng KPin, Pascoal TA, Mathotaarachchi S, Rosa-Neto P, Gauthier S.  2017.  The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database.. Alzheimers Dement (N Y). 3(1):107-113.
Pascoal TA, Mathotaarachchi S, Shin M, Benedet AL, Mohades S, Wang S, Beaudry T, Kang MSu, Soucy J-P, Labbe A et al..  2017.  Synergistic interaction between amyloid and tau predicts the progression to dementia.. Alzheimers Dement. 13(6):644-653.
Sankar T, Park MTae M, Jawa T, Patel R, Bhagwat N, Voineskos AN, Lozano AM, Chakravarty MM.  2017.  Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry.. Hum Brain Mapp. 38(6):2875-2896.
2016
Chung JKu, Nakajima S, Shinagawa S, Plitman E, Chakravarty MM, Iwata Y, Caravaggio F, Pollock BG, Gerretsen P, Graff-Guerrero A.  2016.  Benzodiazepine Use Attenuates Cortical β-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F(18)-Florbetapir Positron Emission Tomography.. Am J Geriatr Psychiatry. 24(11):1028-1039.
Patel S, Park MTae M, Chakravarty MM, Knight J.  2016.  Gene Prioritization for Imaging Genetics Studies Using Gene Ontology and a Stratified False Discovery Rate Approach.. Front Neuroinform. 10:14.
2015
Tam A, Dansereau C, Badhwar AP, Orban P, Belleville S, Chertkow H, Dagher A, Hanganu A, Monchi O, Rosa-Neto P et al..  2015.  Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies.. Front Aging Neurosci. 7:242.
Leduc V, De Beaumont L, Théroux L, Dea D, Aisen P, Petersen RC, Dufour R, Poirier J.  2015.  HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.. Mol Psychiatry. 20(7):867-73.
Chung JKu, Plitman E, Nakajima S, Chow TW, Chakravarty MM, Caravaggio F, Gerretsen P, Brown EE, Iwata Y, Mulsant BH et al..  2015.  Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 45(3):907-19.
Eskildsen SF, Coupé P, Fonov VS, Pruessner JC, D Collins L.  2015.  Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.. Neurobiol Aging. 36 Suppl 1:S23-31.
2014
Pipitone J, Park MTae M, Winterburn J, Lett TA, Lerch JP, Pruessner JC, Lepage M, Voineskos AN, Chakravarty MM.  2014.  Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates.. Neuroimage. 101:494-512.
Peterson D, Munger C, Crowley J, Corcoran C, Cruchaga C, Goate AM, Norton MC, Green RC, Munger RG, Breitner JCS et al..  2014.  Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.. Alzheimers Dement. 10(3):366-71.